Andrew Perry
Corporate Officer/Principal presso G1 THERAPEUTICS, INC.
Patrimonio netto: 256 760 $ in data 30/06/2024
Posizioni attive di Andrew Perry
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 02/08/2021 | - |
Storia della carriera di Andrew Perry
Precedenti posizioni note di Andrew Perry
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - | - |
Formazione di Andrew Perry
| University of Glasgow | Graduate Degree |
| The University of Sheffield | Graduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 4 |
| Stati Uniti | 2 |
Posizioni
| Graduate Degree | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Andrew Perry
- Esperienza
